1-2 of 2
Michaela Grunert
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Novel Technique of Genetically Engineered Patient-Derived Xenografts (GEPDX) Reveals That the X-Linked Inhibitor of Apoptosis Protein (XIAP) Plays an Essential Role for Maintenance and Growth of Patients' Acute Lymphoblastic Leukemia In Vivo

Michela Carlet, PhD, Jenny Vergalli, M.Sc., Cornelia Finkenzeller, M.Sc., Michaela Grunert, PhD, Irmela Jeremias, MD
Journal: Blood
Blood (2015) 126 (23): 2632.
https://doi.org/10.1182/blood.V126.23.2632.2632
Published: 2015
Journal Articles

Leukemia-initiating cells of patient-derived acute lymphoblastic leukemia xenografts are sensitive toward TRAIL

Brief Report
Catarina Castro Alves, Nadia Terziyska, Michaela Grunert, Sibylle Gündisch, Ulrike Graubner, Leticia Quintanilla-Martinez, Irmela Jeremias
Journal: Blood
Blood (2012) 119 (18): 4224–4227.
https://doi.org/10.1182/blood-2011-08-370114
Published: 2012
Includes: Supplemental data